Featured News
-
ACLA Recognizes National Women’s Health Week by Spotlighting the Value of Diagnostic Testing as an Empowering Tool In Disease Prevention and Treatment Decision-Making
WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) today joined with the U.S. Department of Health and Human Services Office on Women’s Health to recognize the week of May 10-16 as National Women’s Health Week and draw attention to diagnostic tests from the common to the cutting edge and how they are playing a role in saving the lives of thousands of American women.Continue Reading »... -
ACLA’s 20th Annual Conference Gathers Legal, Congressional & Regulatory Leaders on FDA’s Role with LDTs, Reimbursement and the Future of Personalized Medicine
WASHINGTON, DC – Scientists, physicians, researchers and lab clinicians will gather today in the nation’s capital to hear lawmakers, regulatory officials and legal experts address the most pressing policy issues of the day for clinical labs at the 20th annual conference of the American Clinical Laboratory Association (ACLA). “The beginning of the 21st century has seen an explosion of diagnostic innovation that is rapidly changingContinue Reading »... -
ACLA Announces New Vice President for Reimbursement and Regulatory Policy
WASHINGTON, DC – The American Clinical Laboratory Association (ACLA) today announced new hire Paul Sheives as the Vice President for Reimbursement and Regulatory Policy for the Washington, D.C.-based association that represents the nation’s leading clinical laboratories on federal and state government policies impacting the industry. “Paul’s impressive professional experience is tailor-made for meeting ACLA’s mission to provide our members with timely information and expert counselContinue Reading »... -
Critical Value of Clinical Lab Testing Illuminated During Medical Lab Professionals Week
WASHINGTON, D.C. – In recognition of the 300,000 medical laboratory professionals across the country who perform and interpret more than 10 billion laboratory tests annually, the American Clinical Laboratory Association (ACLA) today joined the American Society for Clinical Pathology in celebrating Medical Lab Professionals Week from April 19 to 25, 2015. “Diagnostics serve as the foundation for a new age of personalized medicine,” said ACLA PresidentContinue Reading »... -
In Recognition of Healthy Kids Day Lab Community Underscores Value of Diagnostic Tests For Prevalent Childhood Disease
WASHINGTON, DC – As YMCAs across the country prepare to celebrate Healthy Kids Day on April 25th, the American Clinical Laboratory Association (ACLA) today urged parents who may be seeing symptoms of diabetes in their children to ask their doctor if a diagnostic blood test for early detection of diabetes is appropriate. “According to JDRF, each year more than fifteen thousand kids are diagnosedContinue Reading »... -
ACLA Applauds Bi-Partisan Congressional Passage of Legislation to Permanently Reform the Medicare Physician Payment Methodology
WASHINGTON, DC – The American Clinical Laboratory Association (ACLA) today commended Congress for spearheading reform of the Medicaid physician payment process and passing legislation that repeals the Sustainable Growth Rate (SGR), a payment methodology long considered to be problematic by both policymakers and the physician community. “Congress has demonstrated its ability to work together to effect reform and the clinical lab industry commends theContinue Reading »... -
A Statement from the Alliance for Integrity in Medicare (AIM)
WASHINGTON, DC – The Alliance of Integrity in Medicare highlights a new report out by the Congressional Budget Office (CBO) last week that increased the Medicare savings score in the President’s FY 2016 budget for the narrowing In-Office Ancillary Services (IOAS) exception. According to CBO the savings associated with IOAS reform rose $100 million from last year to $3.5 Billion, representing additional Medicare savingsContinue Reading »... -
ACLA Applauds the Inclusion of Medicare Self-Referral Reform in President’s FY 2016 Budget
(Washington, D.C.) – The American Clinical Laboratory Association (ACLA) today applauded the President’s FY 2016 Budget for including the removal of anatomic pathology (AP) from the Medicare in-office ancillary services (IOAS) exception to the federal self-referral law, noting it protects patients and the clinical lab profession. This is the third consecutive year the provision has been included in the President’s annual budget. “The clinicalContinue Reading »... -
ACLA in Comment Letter: FDA Lacks Statutory Authority in Ill-Advised Move to Regulate Laboratory Developed Tests (LDTs) As Devices
WASHINGTON, DC – The American Clinical Laboratory Association (ACLA) today submitted comments to the Food and Drug Administration (FDA) addressing FDA’s draft guidance to newly regulate laboratory developed tests (LDTs), stating the agency lacks the statutory authority to regulate LDTs, is misguided in its attempt to define diagnostic testing services as medical devices and will duplicate existing regulation while hampering innovation. “The clinical laboratory industryContinue Reading »... -
ACLA Lauds President’s Precision Medicine Initiative, Warns FDA Move to Regulate Laboratory Developed Tests (LDTs) Conflicts with White House Proposal
WASHINGTON, DC – The American Clinical Laboratory Association (ACLA) today commended the White House’s Precision Medicine Initiative intended to accelerate advances in disease treatment and cures, but warned the FDA proposal announced last year to regulate laboratory developed testing services (LDTs) will work against the very medical innovation supported by the initiative. “The clinical laboratory community applauds the President’s leadership in the area of personalizedContinue Reading »...
